Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Kumar Shiva Gubbiyappa"'
Publikováno v:
Green Analytical Chemistry, Vol 8, Iss , Pp 100105- (2024)
Ixazomib citrate (IC) is the first oral selective proteosome inhibitor for treating multiple myeloma. IC is prone to degradation due to its oxidative deboronation and the amide bond, affecting patient health, drug quality, and efficacy. The stability
Externí odkaz:
https://doaj.org/article/fa5fef5d9c364212b5a97274c3fe9b69
Publikováno v:
Future Journal of Pharmaceutical Sciences, Vol 8, Iss 1, Pp 1-20 (2022)
Abstract Background Pemigatinib is a small molecule tyrosine kinase inhibitor of fibroblast growth factor receptor inhibitors. The oral bioavailability of Pemigatinib is constricted due to its limited solubility at physiological pH. It is essential t
Externí odkaz:
https://doaj.org/article/094253457ce34e0b8d4e95ffc49effd7
Autor:
Predeepkumar Narayanappa Shiroorkar, Obaid Afzal, Imran Kazmi, Fahad A. Al-Abbasi, Abdulmalik Saleh Alfawaz Altamimi, Kumar Shiva Gubbiyappa, Nagaraja Sreeharsha
Publikováno v:
Molecules, Vol 25, Iss 23, p 5622 (2020)
Sepsis aggregates undesirable immune response causing depression of ventricular myocardium and diastolic dysfunction. This present study examined the effect of a plant-derived flavone tangeretin (TG) on autophagy and reduction in myocardial dysfuncti
Externí odkaz:
https://doaj.org/article/f09abd3efa0e4c6abbfe4a1669b12903
Publikováno v:
BioNanoScience. 13:521-540
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15dc36eaa230a1fe5cffe14d17a756c6
https://doi.org/10.1007/s12668-023-01094-1
https://doi.org/10.1007/s12668-023-01094-1
Publikováno v:
RASAYAN Journal of Chemistry. 16:494-501
A novel, sensitive, and specific LC-MS/MS technique was developed for the quantification of Relugolix in plasma and validated as per the regulatory guidelines. Elution of Relugolix and Canagliflozin was achieved on Inertsil C18 (150mm × 2.10mm i.d,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81c2888f05943fcff760722c09c2ae18
https://doi.org/10.31788/rjc.2023.1618105
https://doi.org/10.31788/rjc.2023.1618105
Bioanalytical Method Development And Validation Of Darunavir In Biological Matrices Using Uplc-Ms-Ms
Publikováno v:
Journal of Pharmaceutical Negative Results. :4979-4986
Background: To develop a simple and accurate method for the determination of Darunavir in human plasma by liquid-liquid extraction method with Verapamil as an internal standard using UPLC-MS/MS. Methods: The separation was achieved on Agilent, Zorbax
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0a249701c3f769e87bb12474d9a05fc
https://doi.org/10.47750/pnr.2022.13.s09.615
https://doi.org/10.47750/pnr.2022.13.s09.615
Publikováno v:
International Journal of Applied Pharmaceutics. :16-33
The most fundamental important extensive constitutive of drug molecules to be available for systemic absorption is aqueous solubility; subsequently, that is the nature of GIT fluid. When the drug molecules become solubilized, it has to reach the syst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::385a2f7a5eafa37a2598226bef57e935
https://doi.org/10.22159/ijap.2022v14i3.44178
https://doi.org/10.22159/ijap.2022v14i3.44178
Publikováno v:
Challenges and Advances in Pharmaceutical Research Vol. 10 ISBN: 9788195958566
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::997a14f41bdead2cf7638eb808b7adb9
https://doi.org/10.9734/bpi/capr/v10/8708f
https://doi.org/10.9734/bpi/capr/v10/8708f
Publikováno v:
Asian Journal of Pharmaceutical and Clinical Research. :40-44
Lipid-based drug delivery systems are extensively reported in the literature for enhancing drug solubility, permeability, and bioavailability. Self-nanoemulsifying drug delivery systems (SNEDDS) are a superior strategy for enhancing solubility and bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8777b8c349d4cdae5eb51989bff3f67
https://doi.org/10.22159/ajpcr.2021.v14i8.41987
https://doi.org/10.22159/ajpcr.2021.v14i8.41987
Autor:
Pingping Li, Syed Nasir Abbas Bukhari, Tahseen Khan, Renukaradhya Chitti, Davan B Bevoor, Anand R Hiremath, Nagaraja SreeHarsha, Yogendra Singh, Kumar Shiva Gubbiyappa
Publikováno v:
International Journal of Nanomedicine.
Li P, Bukhari SNA, Khan T, et al. Int J Nanomedicine. 2020;15:9115–9124. The Editor and Publisher of International Journal of Nanomedicine wish to retract the published article. Concerns were raised regarding the alleged duplication of H&E images i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8e490822b3e9f1c9571c6a312b1b7f8
https://www.dovepress.com/retraction-apigenin-loaded-solid-lipid-nanoparticle-attenuates-diabeti-peer-reviewed-fulltext-article-IJN
https://www.dovepress.com/retraction-apigenin-loaded-solid-lipid-nanoparticle-attenuates-diabeti-peer-reviewed-fulltext-article-IJN